Enzolytics Inc (ENZC)

[foxi]

There is a valid point that Enzoimmune Active is supposed to have 20x lower toxicity than Tamiflu. The reference to Tamiflu actually comes from ENZC's own PR. Godfather did cite this source

$ENZC - 💥IMMUNOMODULATOR💥

The Immunomodulator market is worth $240Billion (2026). EnzoImmune Active® addresses this market as its applicable to many diseases.

Tamiflu alone is worth $940MM, yet our product is more effective at a lower dosage and 20x less toxic!

READ 👇 https://t.co/K8LW4QRK7v pic.twitter.com/Ri5Yw8WlWO

— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) November 3, 2021

I agree with your points about not speculating an unrealistically high valuation, given Tamiflu is FDA Approved, already a household name, and Enzoimmune Active will potentially be priced far lower. And further, ENZC may only be entitled to 50% of Enzoimmune Active profits, if the deal with the "European pharma entity" referenced in ENZC's OTC disclosures is indeed the deal struck between ENZC and Rosetta.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166692585


Edit: not sure why your message was deleted, it seemed like a valid analysis. :/ Maybe too ad hominem.